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Noninvasive Assessment of Coronary Artery
Bypass Graft Disease
The Potential Role of Contrast-Enhanced Cardiac Magnetic Resonance*
Sven Plein, MD, PHD
Leeds, United KingdomRecurrent or persistent angina pectoris in patients
with previous coronary artery bypass graft (CABG)
surgery is a common diagnostic and therapeutic
challenge. In 2005, 469,000 CABG operations
were performed in the U.S. alone (1). Many of
these patients require reassessment once or several
times after their initial operation because of symp-
tom recurrence. Early after surgery, this is usually
caused by technical graft failure or graft thrombosis,
whereas in the long term, degenerative graft disease
and progression of atherosclerosis in nongrafted
vessels are responsible. The scale of this clinical
problem is illustrated by the fact that 15 years after
CABG, 50% of vein grafts and as many as 20% of
arterial grafts are occluded, and many nonoccluded
vein grafts have developed significant atheroscle-
rotic disease (2,3).
See page 437
The management of graft disease is complicated
in that all interventional therapies are technically
challenging and have poor long-term outcomes.
Patients with previous CABG are usually of ad-
vanced age, have significant comorbidities, and
often have diffuse atherosclerosis. Re-do CABG,
therefore, carries a substantially higher periopera-
tive mortality and complication rate than the initial
procedure and risks damage to any remaining func-
tional grafts, in particular the internal mammary
conduits (4). Percutaneous graft angioplasty, while
increasingly performed, is fraught with challenges
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.From the Division of Cardiovascular and Neuronal Remodelling, Uni-
versity of Leeds, Leeds, United Kingdom.such as distal embolization, high rates of restenosis,
and new lesion development as high as 50% at 1
year (5), although the combination of drug-eluting
stents with embolic protection devices may eventu-
ally improve these outcomes.
In light of the challenges in treating bypass graft
disease, revascularization decisions need particularly
careful strategic planning and risk assessment. Because
basic diagnostic tests such as exercise tolerance testing
are usually unhelpful in this patient group due to
abnormal resting electrocardiograms, guidelines rec-
ommend the early use of imaging tests (6). The
clinician is already spoiled for choice with regard to
available imaging modalities, and myocardial perfu-
sion scintigraphy or stress echocardiography can de-
tect, localize, and quantify ischemia after CABG
surgery and have prognostic value (7,8). More re-
cently, cardiac computed tomography (CCT) has
matured into a highly accurate test to visualize graft
stenosis with sensitivities and specificities in excess of
95% (9). Although that makes CCT by far the most
accurate noninvasive test to detect graft disease, the
method remains limited by the lack of the all-
important functional assessment of any observed
stenosis.
In this issue of iJACC, Klein et al. (10) propose
myocardial perfusion cardiac magnetic resonance
(CMR) imaging as another potential noninvasive
test for the detection of graft disease (10). The use
of CMR for graft assessment is itself not new, and
as long as 20 years ago, CMR was used for
noninvasive graft angiography and flow assessment,
albeit with limited diagnostic performance (11).
Perhaps surprisingly, though, myocardial perfusion
CMR has hitherto not been used for graft assess-
ment. In the present study, Klein et al. (10) studied
78 patients with a disease prevalence of 69% at a
m
p
7
s
q
r
r
l
c
t
t
l
a
p
t
p
c
u
o
i
u
c
g
t
e
m
g
m
L
p
t
C
d
t
(
s
p
C
t
w
s
r
s
h
t
C
d
d
C
a
C
W
s
s
b
v
s
s
s
p
C
p
t
C
n
p
a
a
s
H
g
p
c
s
c
g
R
v
U
e
R
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 2 , N O . 4 , 2 0 0 9
A P R I L 2 0 0 9 : 4 4 6 – 8
Plein
Editorial Comment
447ean of 8 years after CABG. In this high-risk
opulation, perfusion CMR had a sensitivity of
7% and specificity of 90% to identify patients with
ignificant graft or native vessel stenosis on subse-
uent X-ray angiography. CMR was equally accu-
ate in localizing disease to vessel territories. These
esults are very much in line with the existing
iterature of perfusion scintigraphy and stress echo-
ardiography, and thus provide a first indication
hat perfusion CMR could be an alternative test for
he detection of ischemia after CABG.
However, similar diagnostic accuracy as estab-
ished tests is not sufficient justification to adopt
new test for clinical application—unless it
rovides some other unique diagnostic informa-
ion. With its focus on diagnostic accuracy of the
erfusion analysis, the study by Klein et al. (10)
an give merely a glimpse of what makes CMR
nique in the assessment of patients with previ-
us bypass surgery. CMR is the most versatile
maging modality currently available and can be
sed to interrogate many facets of myocardial and
oronary morphology and function. With the late
adolinium enhancement (LGE) method in par-
icular, CMR provides the most detailed delin-
ation of myocardial scar of any current imaging
odality (12). This method is now widely re-
arded as the reference test for viability assess-
ent and, as in the study by Klein et al. (10),
GE can be very usefully combined with stress
erfusion imaging. This combination is of par-
icular relevance for patients with previous
ABG surgery, because they have more complex
isease and a high incidence of previous infarc-
ion; in the study by Klein et al. (10), it was 63%
49 of 78 patients). Importantly, the current
tudy has demonstrated for the first time that
eri-infarct ischemia can be detected by perfusion
MR with an impressive sensitivity of 88% in
his cohort. Furthermore, 7 of the 54 patients
ith significant stenosis had transmural LGE,
uggesting that revascularization to these territo-AJ, et al. Coronary bypass graft fate 1985;90:668–75.essment of ischemia and scar, with substantially
igher spatial detail than with other imaging
ests, is likely to be the main motivation for using
MR for assessing patients with coronary artery
isease in general and for those with complex
isease or previous bypass surgery in particular.
But the appealing combination of perfusion
MR with LGE, and with it the study by Klein et
l. (10), has limitations. Contemporary perfusion
MR methods typically cover 3 myocardial slices.
hile this is sufficient to evaluate 16 myocardial
egments, the LGE method covers the entire heart
o that the extent of peri-infarct ischemia may not
e fully appreciated on CMR. Furthermore, con-
entional perfusion CMR affords only half the
patial resolution compared with LGE, so that the
patial correlation of scar and ischemia within each
ection can be challenging. Recent innovations that
ermit high-resolution or 3-dimensional perfusion
MR with whole-heart coverage have been pro-
osed and tested in feasibility studies (13,14). With
hese methods, the current limitations of perfusion
MR may soon be overcome, creating a powerful
ew tool for the precise correlation of scar and the
resence and degree of peri-infarct ischemia.
In summary, the work by Klein et al. (10) gives
first indication that CMR can be used to detect
nd localize ischemia in high-risk patients with
ymptom recurrence late after CABG surgery.
owever, CMR promises more than noninvasive
ate-keeping for X-ray angiography, which can
robably be most reliably delivered by CCT, and
ombined with LGE assessment of scar, perfu-
ion CMR can provide a detailed guide to revas-
ularization decisions for this challenging patient
roup.
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